Literature DB >> 17627943

Distinct mechanisms for Ctr1-mediated copper and cisplatin transport.

Devis Sinani1, David J Adle, Heejeong Kim, Jaekwon Lee.   

Abstract

The Ctr1 family of integral membrane proteins is necessary for high affinity copper uptake in eukaryotes. Ctr1 is also involved in cellular accumulation of cisplatin, a platinum-based anticancer drug. Although the physiological role of Ctr1 has been revealed, the mechanism of action of Ctr1 remains to be elucidated. To gain a better understanding of Ctr1-mediated copper and cisplatin transport, we have monitored molecular dynamics and transport activities of yeast Saccharomyces cerevisiae Ctr1 and its mutant alleles. Co-expression of functional Ctr1 monomers fused with either cyan or yellow fluorescent protein resulted in fluorescence resonance energy transfer (FRET), which is consistent with multimer assembly of Ctr1. Copper near the K(m) value of Ctr1 enhanced FRET in a manner that correlated with cellular copper transport. In vitro cross-linking of Ctr1 confirmed that copper-induced FRET reflects conformational changes within pre-existing Ctr1 complexes. FRET assays in membrane-disrupted cells and protein extracts showed that intact cell structure is necessary for Ctr1 activity. Despite Ctr1-dependent cellular accumulation, cisplatin did not change Ctr1 FRET nor did it attenuate copper-induced FRET. A Ctr1 allele defective in copper transport enhanced cellular cisplatin accumulation. N-terminal methionine-rich motifs that are dispensable for copper transport play a critical role for cisplatin uptake. Taken together, our data reveal functional roles for structural remodeling of the Ctr1 multimeric complex in copper transport and suggest distinct mechanisms employed by Ctr1 for copper and cisplatin transport.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627943     DOI: 10.1074/jbc.M703973200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.

Authors:  Christopher A Larson; Preston L Adams; Danielle D Jandial; Brian G Blair; Roohangiz Safaei; Stephen B Howell
Journal:  Biochem Pharmacol       Date:  2010-05-06       Impact factor: 5.858

Review 2.  Human copper transporters: mechanism, role in human diseases and therapeutic potential.

Authors:  Arnab Gupta; Svetlana Lutsenko
Journal:  Future Med Chem       Date:  2009-09       Impact factor: 3.808

3.  RNA-Pt adducts following cisplatin treatment of Saccharomyces cerevisiae.

Authors:  Alethia A Hostetter; Maire F Osborn; Victoria J DeRose
Journal:  ACS Chem Biol       Date:  2011-11-15       Impact factor: 5.100

Review 4.  New roles for copper metabolism in cell proliferation, signaling, and disease.

Authors:  Michelle L Turski; Dennis J Thiele
Journal:  J Biol Chem       Date:  2008-08-29       Impact factor: 5.157

5.  Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells.

Authors:  Mia C Akerfeldt; Carmen M-N Tran; Clara Shen; Trevor W Hambley; Elizabeth J New
Journal:  J Biol Inorg Chem       Date:  2017-05-17       Impact factor: 3.358

Review 6.  Metal transport across biomembranes: emerging models for a distinct chemistry.

Authors:  José M Argüello; Daniel Raimunda; Manuel González-Guerrero
Journal:  J Biol Chem       Date:  2012-03-02       Impact factor: 5.157

7.  Role of copper transporters in resistance to platinating agents.

Authors:  Cara A Rabik; Edward B Maryon; Kristen Kasza; John T Shafer; Catherine M Bartnik; M Eileen Dolan
Journal:  Cancer Chemother Pharmacol       Date:  2008-11-08       Impact factor: 3.333

8.  The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs.

Authors:  Christopher A Larson; Brian G Blair; Roohangiz Safaei; Stephen B Howell
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

9.  Copper-dependent trafficking of the Ctr4-Ctr5 copper transporting complex.

Authors:  Raphaël Ioannoni; Jude Beaudoin; Alexandre Mercier; Simon Labbé
Journal:  PLoS One       Date:  2010-08-04       Impact factor: 3.240

10.  Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4.

Authors:  Cheng-Yu Tsai; Christopher A Larson; Roohangiz Safaei; Stephen B Howell
Journal:  Biochem Pharmacol       Date:  2014-06-23       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.